semaglutide medication cincinnati doctor warns about weight loss drug use Wegovy vs. Zepbound: A Comparison

doi: 10.1016/j.cbi.2013.02.006

Se usa mediante una inyeccin diaria y tambin presenta un efecto sobre la prdida de peso, aunque no est indicado oficialmente con este fin

-These shortages have forced Hospira to prioritize certain markets, resulting in tightening supply and forcing price increases

In the STEP 5 trials , participants receiving Semaglutide experienced an average weight loss of approximately 15% of their initial body weight over 68 weeks, significantly outperforming placebo groups

Reference #18.9d0c0317.1784433397.ac7ba05c

Implications for employers: This study is consistent with other studies of GLP-1 medications for both diabetes and obesity demonstrating substantial cardiovascular and metabolic benefits of this class of medications